Lenvatinib Plus PD-1 Inhibitors as First-Line Treatment in Patients With Unresectable Biliary Tract Cancer: A Single-Arm, Open-Label, Phase II Study
Qiyi Zhang(Blood Center of Zhejiang Province), Sheng Yan(Blood Center of Zhejiang Province)
Cited by 79
Related Papers
Bioinspired pH-Responsive Microalgal Hydrogels for Oral Insulin Delivery with Both Hypoglycemic and Insulin Sensitizing Effects
|ACS Nano|2023|98
Study on the interaction between 2,6-dihydroxybenzoic acid nicotine salt and human serum albumin by multi-spectroscopy and molecular dynamics simulation
|Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy|2022|35